Identification of Patients at Risk of CKD After AKI

Last updated: January 22, 2024
Sponsor: Guy's and St Thomas' NHS Foundation Trust
Overall Status: Active - Recruiting

Phase

N/A

Condition

Kidney Failure

Kidney Disease

Renal Failure

Treatment

N/A

Clinical Study ID

NCT05740709
IRAS 319992
  • Ages > 18
  • All Genders

Study Summary

The investigators will investigate whether new kidney biomarkers can identify patients who are at risk of chronic kidney disease after an episode of moderate / severe acute kidney injury in ICU.

Eligibility Criteria

Inclusion

Inclusion Criteria: critically ill adult patients who had AKI stage II or III whilst in ICU and are scheduledto be discharged from hospital

Exclusion

Exclusion Criteria:

  1. known pre-existing end-stage kidney disease or advanced CKD (stage 3b or worse)
  2. kidney transplant within the last 12 months
  3. known primary renal disease
  4. discharge from hospital for end-of-life care
  5. transfer to another health care institution for ongoing in-patient care
  6. not expected to survive for 3 months
  7. pregnancy
  8. lack of capacity to give consent
  9. receiving regular dialysis at hospital discharge
  10. CKD stage 3 or worse at hospital discharge

Study Design

Total Participants: 100
Study Start date:
March 01, 2023
Estimated Completion Date:
January 01, 2026

Study Description

Acute kidney injury (AKI) is a common complication during critical illness and associated with serious short and long-term complications. Participants with AKI have an increased risk of developing dysfunction of other organs, including multi-organ failure, a longer stay in hospital and a higher risk of dying. Survivors remain at risk of complications, even if kidney function initially recovers. In particular, they are at high risk of developing chronic kidney disease, dialysis-dependent end-stage kidney disease and cardiovascular comorbidities. At present, the tools to identify patients at highest risk of chronic kidney disease (CKD) are very limited.

The investigators will recruit participants who had AKI whilst in ICU and are scheduled to be discharged from hospital. Within 3 days of discharge from hospital, blood and urine kidney biomarkers will be measured to explore whether there is a correlation with renal function 3 months later and to identify those at highest risk of CKD. In addition, quality of life at 3 months will be assessed.

Connect with a study center

  • Guy's & St Thomas Foundation Hospital

    London, SE1 7EH
    United Kingdom

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.